Daxor (DXR) Stock Analysis
NASDAQHealthcareMedical - Instruments & Supplies
What Daxor does
Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.
Key metrics
ETFs linked to DXR
Broad-market and Healthcare sector ETFs an investor holding Daxor is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how DXR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze DXR in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Daxor?
- Daxor trades under the ticker DXR on NASDAQ.
- Which exchange is DXR listed on?
- DXR is listed on NASDAQ.
- What sector does Daxor operate in?
- Daxor is classified in the Healthcare sector (Medical - Instruments & Supplies industry).
- How can PortView help analyze DXR in a portfolio?
- PortView shows DXR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.